SC
JANX icon

Steven Cohen’s Janux Therapeutics JANX Stock Holding History

Steven Cohen’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6M Buy
1,993,837
+837,697
+72% +$12.1M 0.03% 645
2026
Q1 		$16.1M Buy
1,156,140
+194,321
+20% +$2.66M 0.02% 933
2025
Q4 		$13.3M Sell
961,819
-748,381
-44% -$17.6M 0.01% 1173
2025
Q3 		$41.8M Sell
1,710,200
-433,700
-20% -$10.6M 0.07% 307
2025
Q2 		$49.5M Buy
2,143,900
+1,767,238
+469% +$46.6M 0.1% 251
2025
Q1 		$10.2M Sell
376,662
-244,721
-39% -$9.22M 0.02% 677
2024
Q4 		$33.3M Buy
621,383
+225,508
+57% +$11.9M 0.07% 315
2024
Q3 		$18M Buy
395,875
+259,445
+190% +$11.3M 0.05% 447
2024
Q2 		$5.72M Buy
+136,430
New +$6.41M 0.02% 797

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Steven Cohen's JANX Position: Q2 2026 in Review

Steven Cohen increased its Janux Therapeutics (JANX) stake by 72% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,993,837 shares worth $30.6M. The position accounts for 0.03% of the portfolio, ranked #645.

Steven Cohen first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. The position peaked at $49.5M in Q2 2025. 196 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Steven Cohen held 1,993,837 shares of Janux Therapeutics worth $30.6M as of Q2 2026.
  • Steven Cohen bought 837,697 Janux Therapeutics shares in Q2 2026, an estimated $12.1M.
  • Janux Therapeutics made up 0.03% of Steven Cohen's portfolio in Q2 2026, its #645 holding.
  • Steven Cohen first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Steven Cohen's Janux Therapeutics position peaked at $49.5M in Q2 2025.
  • 196 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.